123 related articles for article (PubMed ID: 37898426)
1. Prostaglandin 15d-PGJ
Slanovc J; Mikulčić M; Jahn N; Wizsy NGT; Sattler W; Malle E; Hrzenjak A
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166924. PubMed ID: 37898426
[TBL] [Abstract][Full Text] [Related]
2. 15d-PGJ
Mikulčić M; Tabrizi-Wizsy NG; Bernhart EM; Asslaber M; Trummer C; Windischhofer W; Sattler W; Malle E; Hrzenjak A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769194
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.
Yen CC; Hsiao CD; Chen WM; Wen YS; Lin YC; Chang TW; Yao FY; Hung SC; Wang JY; Chiu JH; Wang HW; Lin CH; Chen TH; Chen PC; Liu CL; Tzeng CH; Fletcher JA
Oncotarget; 2014 Feb; 5(3):716-25. PubMed ID: 24566468
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
5. TFEB, a master regulator of autophagy and biogenesis, unexpectedly promotes apoptosis in response to the cyclopentenone prostaglandin 15d-PGJ2.
Yang CB; Liu J; Tong BC; Wang ZY; Zhu Z; Su CF; Sreenivasmurthy SG; Wu JX; Iyaswamy A; Krishnamoorthi S; Huang SY; Cheung KH; Song JX; Tan JQ; Lu JH; Li M
Acta Pharmacol Sin; 2022 May; 43(5):1251-1263. PubMed ID: 34417577
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
7. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
Siavash H; Nikitakis NG; Sauk JJ
Cancer Lett; 2004 Jul; 211(1):97-103. PubMed ID: 15194221
[TBL] [Abstract][Full Text] [Related]
8. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.
Koyani CN; Kitz K; Rossmann C; Bernhart E; Huber E; Trummer C; Windischhofer W; Sattler W; Malle E
Biochem Pharmacol; 2016 Mar; 104():29-41. PubMed ID: 26801686
[TBL] [Abstract][Full Text] [Related]
9. Novel SIRT1 inhibitor 15-deoxy-Δ12,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells.
Tae IH; Park EY; Dey P; Son JY; Lee SY; Jung JH; Saloni S; Kim MH; Kim HS
Int J Oncol; 2018 Dec; 53(6):2518-2530. PubMed ID: 30221742
[TBL] [Abstract][Full Text] [Related]
10. Physiological and Pathological Roles of 15-Deoxy-Δ
Yagami T; Yamamoto Y; Koma H
Mol Neurobiol; 2018 Mar; 55(3):2227-2248. PubMed ID: 28299574
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress.
Chen SY; Lu FJ; Gau RJ; Yang ML; Huang TS
Anticancer Drugs; 2002 Aug; 13(7):759-65. PubMed ID: 12187333
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
[TBL] [Abstract][Full Text] [Related]
14. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-Δ
Chen K; Li JJ; Li SN; Feng J; Liu T; Wang F; Dai WQ; Xia YJ; Lu J; Zhou YQ; Guo CY
Acta Pharmacol Sin; 2017 May; 38(5):672-687. PubMed ID: 28216619
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-Δ
Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
[TBL] [Abstract][Full Text] [Related]
19. 15d-PGJ2: the anti-inflammatory prostaglandin?
Scher JU; Pillinger MH
Clin Immunol; 2005 Feb; 114(2):100-9. PubMed ID: 15639643
[TBL] [Abstract][Full Text] [Related]
20. 15-Deoxy-Δ
Na HK; Yang H; Surh YJ
J Cancer Prev; 2020 Jun; 25(2):100-110. PubMed ID: 32647651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
